Possible association between donepezil and worsening Parkinson's disease

被引：42

作者：

Bourke, D ^{[3
]}

Druckenbrod, RW

机构：

[1] Campbell Univ, Sch Pharm, Durham, NC 27705 USA

[2] Methodist Retirement Community, Durham, NC 27705 USA

[3] CVS Pharm, Morrisville, NC 27560 USA

来源：

ANNALS OF PHARMACOTHERAPY | 1998年 / 32卷 / 05期

关键词：

D O I：

10.1345/aph.17355

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：610 / 611

页数：2

相关论文

共 4 条

[1] EXACERBATION OF PARKINSONISM BY TACRINE
OTT, BR
LANNON, MC
[J]. CLINICAL NEUROPHARMACOLOGY, 1992, 15 (04) : 322 - 325
[2] The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial
Rogers, SL
Friedhoff, LT
Apter, JT
Richter, RW
Hartford, JT
Walshe, TM
Baumel, B
Linden, RD
Kinney, FC
Doody, RS
Borison, RL
Ahem, GL
[J]. DEMENTIA, 1996, 7 (06): : 293 - 303
[3] Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia
Trzepacz, PT
Ho, V
Mallavarapu, H
[J]. PSYCHOSOMATICS, 1996, 37 (03) : 299 - 301
[4] *US PHARM CONV, 1997, USP DI DRUG INF HLTH, V1, P2740